Erez Chimovits, Director, 10% Owner at Braveheart Bio, Inc. (BRVE), bought 1,940,000 shares at $18.00 ($34.9M) on 2026-08-07, disclosed to the SEC on 2026-08-11.
Braveheart Bio Director Erez Chimovits purchased 1.67 million shares at $18.00 for approximately $3.0 million, marking the largest purchase of his career. This significant insider buying follows the company's completion of its IPO and listing on the Nasdaq Global Market.
Insufficient data — needs manual review
Insufficient data — needs manual review
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.00 | 273,333 | $4.9M | 14.1% |
| 2 | $18.00 | 1,666,667 | $30.0M | 85.9% |
| Total | $18.00 avg | 1,940,000 | $34.9M | 100% |
| Filing → |
| PHGE | BUY | 2019-12-20 | $36K | — | Filing → |
| PHGE | BUY | 2019-12-12 | $78K | — | Filing → |
| PHGE | BUY | 2019-12-09 | $86K | — | Filing → |